Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Long-Term Debt of $49.41 million for fiscal year 2025.
LEXICON PHARMACEUTICALS, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $49.41M | -50.7% |
| 2024 | $100.30M | +0.8% |
| 2023 | $99.51M | +104.8% |
| 2022 | $48.58M | — |
| 2021 | $0.00 | — |
| 2020 | $0.00 | -100.0% |
| 2019 | $234.17M | -4.0% |
| 2018 | $243.89M | +5.3% |
| 2017 | $231.58M | +171.9% |
| 2016 | $85.17M | -15.6% |
| 2015 | $100.96M | +15.4% |
| 2014 | $87.50M | +333.9% |
| 2013 | $20.17M | -7.8% |
| 2012 | $21.88M | -6.7% |
| 2011 | $23.45M | -14.2% |
| 2010 | $27.34M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $56.51M | -43.4% | +0.7% |
| June 30, 2025 | $56.11M | -43.6% | -4.3% |
| March 31, 2025 | $58.64M | -41.3% | -41.5% |
| December 31, 2024 | $100.30M | +0.8% | +0.4% |
| September 30, 2024 | $99.89M | +0.6% | +0.4% |
| June 30, 2024 | $99.50M | +0.7% | -0.4% |
| March 31, 2024 | $99.87M | +104.5% | +0.4% |
| December 31, 2023 | $99.51M | +104.8% | +0.2% |
- LEXICON PHARMACEUTICALS, INC. showed a decrease of -50.7% in Long-Term Debt compared to the prior fiscal year.
- Over the 2010–2025 period, LEXICON PHARMACEUTICALS, INC.’s long-term debt has grown by 80.7% (from $27.34 million to $49.41 million).
- The most recent figure is from LEXICON PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: